Literature DB >> 3780052

Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo.

R Veerhuis, M C Krol, L A van Es, M R Daha.   

Abstract

In this study the similarities and differences in kinetics and site of clearance of particulate immune complexes and soluble aggregates of IgG (AIgG) were compared in rats. The rate of clearance of both antibody-coated erythrocytes (EA) and AIgG was dependent on the number of IgG molecules per EA or AIgG. Both probes were rapidly taken up by the liver. Whereas a minor part of the AIgG returned to the circulation as TCA-soluble breakdown products, a substantial part of the injected EA returned to the circulation as intact cells after 4 min. This rebound mechanism was shown to be complement (C)-dependent. Immediately after injection the injected EA bound C3 on their surface, whereafter the number of C3-bearing cells in the circulation rapidly decreased (T1/2 7.2 min). In C-depleted rats relatively more EA were taken up by the spleen than by the liver, in comparison with EA injected into normal rats (liver/spleen ratio in C-depleted rats 0.4 +/- 0.1; in normal rats 2.1 +/- 0.4). When C3 was bound and inactivated by preincubation of EA in vitro, a similar shift from liver to spleen (liver/spleen ratio 0.4 +/- 0.1) was observed. It is suggested that when the hepatic C receptors do not participate, the splenic Fc receptors become relatively more important in the clearance of EA from the circulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3780052     DOI: 10.1016/0090-1229(86)90008-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  8 in total

1.  Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy.

Authors:  C Halma; M R Daha; R van Furth; J A Camps; J H Evers-Schouten; E K Pauwels; S Lobatto; L A Van Es
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

3.  Complement-mediated enhancement of IgA-induced H2O2 release by human polymorphonuclear leucocytes.

Authors:  A Gorter; P S Hiemstra; P C Leijh; M E van der Sluys; M T van den Barselaar; L A Van Es; M R Daha
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

4.  Fc gamma receptor-dependent clearance is enhanced following lipopolysaccharide in vivo treatment.

Authors:  M S Palermo; F Alves Rosa; G Fernández Alonso; M A Isturiz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

Review 5.  In vivo clearance by the mononuclear phagocyte system in humans: an overview of methods and their interpretation.

Authors:  C Halma; M R Daha; L A van Es
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  Deficiency of complement component C3 is associated with accelerated removal of soluble 123I-labelled aggregates of IgG from the circulation.

Authors:  C Halma; M R Daha; J A Camps; J H Evers-Schouten; E K Pauwels; E s Van
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

8.  Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.

Authors:  S Lobatto; M R Daha; F C Breedveld; E K Pauwels; J H Evers-Schouten; A A Voetman; A Cats; L A Van Es
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.